Concepedia

Publication | Closed Access

Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data

DOI

44

Citations

19

References

2013

Year

Frederik Temmerman, Tom J.G. Gevers, Tsung-Yeh Ho, Ragna Vanslembrouck, Walter Coudyzer, Jos van Pelt, Bert Bammens, Yves Pirson, Joost P.H. Drenth, Frederik Nevens
Alimentary Pharmacology & Therapeutics

Abstract

Both LAN 90 mg and LAN 120 mg reduce liver volume. LAN 90 mg has less side effects. This suggests that in case of intolerance to LAN 120 mg, a dose reduction to LAN 90 mg is meaningful.

References

YearCitations

Page 1